Skip to content

Efficacy of trial drugs in treatment of skin infections

VALIDATION OF MODERN LABORATORY PARAMETERS IN RAKTAPRADOSAJA VIKARA w.s.r TO TVAKA MANIFESTATION OF VIDRADHI AND COMPARATIVE ANALYSIS OF CLINICO-EXPERIMENTAL ANTIBACTERIAL EFFICACY OF TRIAL DRUGS

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027723
Enrollment
60
Registered
2020-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L029- Cutaneous abscess, furuncle and carbuncle, unspecified

Interventions

Intervention1: Shigru Kwatha: 40 ml before meals twice a day for 30 days Control Intervention1: Shwetavarshabhvadi Kashaya: 40 ml before meals twice a day for 30 days

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who have signs and symptoms of bahya vidradhi with history of raktadushti nidana sevana as per classical texts. 2.All type of external pyogenic abscess. 3.Patients with age 16 years onwards irrespective of sex, caste and religion.

Exclusion criteria

Exclusion criteria: 1.Patients who will not satisfy the preliminary screening test based on sign and symptoms of bahya vidradhi. 2.Patients with abhyantara vidradhi and agantuja vidradhi. 3.Vidradhi related with madhumeha pidika. 4.Pregnancy, Lactation, Immunodeficiency condition. 5.Known hypersensitivity to any of trial drug. 6.Patients suffering from major systemic disorders like renal disease,cardiac disease, diabetes mellitus, thyroid disease, any malignancy, contagious disease.

Design outcomes

Primary

MeasureTime frame
relief in sign and symptoms in patients of vidradhiTimepoint: 4 weeks

Secondary

MeasureTime frame
comparative analysis of clinical and experimental antibacterial efficacy of trial drugs.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactManita Ahlawat

National Institute Of Ayurveda Jaipur

gpawankumar@rediffmail.com8005841032

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026